Membrane-Active Peptides from Marine Organisms—Antimicrobials, Cell-Penetrating Peptides and Peptide Toxins: Applications and Prospects

Probiotics and Antimicrobial Proteins

Volumn 7, Issue 1, 2015, Pages 75-89

  Ponnappan, Nisha ^a   Budagavi, Deepthi Poornima ^a   Yadav, Bhoopesh Kumar ^a   Chugh, Archana ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Bioactive peptides; Drug delivery; Drug discovery; Marine biodiversity; Peptide based therapeutics

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; CELL PENETRATING PEPTIDE; EQUINATOXIN; JASPAMIDE; MARINE TOXIN; PARDAXIN; PENETRATIN; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TACHYPLESIN; MEMBRANE PROTEIN; TOXIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CIONA INTESTINALIS; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG STABILITY; HALOGENATION; MARINE ENVIRONMENT; MARINE SPECIES; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE; AQUATIC SPECIES; CHEMICAL STRUCTURE; CHEMISTRY; HALF LIFE TIME; HUMAN;

ANTI-INFECTIVE AGENTS; AQUATIC ORGANISMS; CELL-PENETRATING PEPTIDES; HALF-LIFE; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR; PROTEIN PROCESSING, POST-TRANSLATIONAL; TOXINS, BIOLOGICAL;

EID: 84925481427     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-014-9182-2     Document Type: Article

References (153)

1. Jha RK, Zi-rong X (2004) Biomedical compounds from marine organisms. Mar Drugs 2:123–146. doi:10.3390/md203123
2. Aneiros A, Garateix A (2004) Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J Chromatogr, B: Anal Technol Biomed Life Sci 803:41–53. doi:10.1016/j.jchromb.2003.11.005
3. Donia M, Hamann MT (2003) Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis 3:338–348
4. Simmons TL, Andrianasolo E, McPhail K et al (2005) Marine natural products as anticancer drugs. Mol Cancer Ther 4:333–342
5. Galdiero S, Falanga A, Cantisani M et al (2013) Peptide-lipid interactions: experiments and applications. Int J Mol Sci 14:18758–18789. doi:10.3390/ijms140918758
6. Wang Q, Hong G, Johnson GR et al (2010) Biophysical properties of membrane-active peptides based on micelle modeling: a case study of cell-penetrating and antimicrobial peptides. J Phys Chem B 114:13726–13735. doi:10.1021/jp1069362
7. Wadhwani P, Reichert J, Bürck J, Ulrich AS (2012) Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation. Eur Biophys J 41:177–187. doi:10.1007/s00249-011-0771-7
8. Tincu JA, Taylor SW (2004) Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother 48:3645–3654. doi:10.1128/AAC.48.10.3645-3654.2004
9. Heitz F, Morris MC, Divita G (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195–206. doi:10.1111/j.1476-5381.2009.00057.x
10. Matsuzaki K, Yoneyama S, Murase O, Miyajima K (1996) Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35:8450–8456. doi:10.1021/bi960342a
11. Kerkis A, Kerkis I, Rádis-Baptista G et al (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J 18:1407–1409. doi:10.1096/fj.03-1459fje
12. Estève E, Mabrouk K, Dupuis A et al (2005) Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem 280:12833–12839. doi:10.1074/jbc.M412521200
13. Gurrola GB, Capes EM, Zamudio FZ et al (2010) Imperatoxin A, a cell-penetrating peptide from scorpion venom, as a probe of Ca-release channels/ryanodine receptors. Pharmaceuticals (Basel) 3:1093–1107. doi:10.3390/ph3041093
14. Hancock RE, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323
15. Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: from genes to applications. doi:10.1007/978-1-4419-7692-5
16. Goldman MJ, Anderson GM, Stolzenberg ED et al (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–560
17. Hancock RE, Scott MG (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97:8856–8861
18. Vizioli J, Salzet M (2002) Antimicrobial peptides versus parasitic infections? Trends Parasitol 18:475–476
19. Baltzer SA, Brown MH (2011) Antimicrobial peptides: promising alternatives to conventional antibiotics. J Mol Microbiol Biotechnol 20:228–235. doi:10.1159/000331009
20. Allsopp M, Pambuccian SE, Johnston P, Santillo D (2009) State of the world’s oceans
21. Wang G, Li X, Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37:D933–D937. doi:10.1093/nar/gkn823
22. Ammerman JW, Fuhrman JA, Hagstrom A, Azam F (1984) Bacterioplankton growth in seawater: I. Growth kinetics and cellular characteristics in seawater cultures. Mar Ecol Prog Ser 18:31–39
23. Patrzykat A, Douglas SE (2003) Gone gene fishing: how to catch novel marine antimicrobials. Trends Biotechnol 21:362–369. doi:10.1016/S0167-7799(03)00145-8
24. Otero-González AJ, Magalhães BS, Garcia-Villarino M et al (2010) Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control. FASEB J 24:1320–1334. doi:10.1096/fj.09-143388
25. Smith VJ, Desbois AP, Dyrynda EA (2010) Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar Drugs 8:1213–1262. doi:10.3390/md8041213
26. Sperstad SV, Haug T, Blencke H-M et al (2011) Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. Biotechnol Adv 29:519–530. doi:10.1016/j.biotechadv.2011.05.021
27. Wang G (2012) Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering. Curr Biotechnol 1:72–79
28. Shinnar AE, Butler KL, Park HJ (2003) Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance. Bioorg Chem 31:425–436. doi:10.1016/S0045-2068(03)00080-4
29. Li C, Haug T, Styrvold OB et al (2008) Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev Comp Immunol 32:1430–1440. doi:10.1016/j.dci.2008.06.013
30. Lee IH, Cho Y, Lehrer RI (1997) Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava. Comp Biochem Physiol B: Biochem Mol Biol 118:515–521
31. Taylor SW, Craig AG, Fischer WH et al (2000) Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. J Biol Chem 275:38417–38426. doi:10.1074/jbc.M006762200
32. Zabriskie TM, Klocke JA, Ireland CM et al (1986) Jaspamide, a modified peptide from a Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc 108:3123–3124. doi:10.1021/ja00271a062
33. Fedders H, Michalek M, Grötzinger J, Leippe M (2008) An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis. Biochem J 416:65–75. doi:10.1042/BJ20080398
34. Andrès E, Dimarcq JL (2004) Cationic antimicrobial peptides: update of clinical development. J Intern Med 255:519–520. doi:10.1046/j.1365-2796.2003.01278.x
35. Ge Y, MacDonald DL, Holroyd KJ et al (1999) In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43:782–788
36. Lamb HM, Wiseman LR (1998) Pexiganan acetate. Drugs 56:1047–1052 (discussion 1053–4)
37. Trotti A, Garden A, Warde P et al (2004) A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 58:674–681. doi:10.1016/S0360-3016(03)01627-4
38. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468–472. doi:10.1016/j.coph.2006.04.006
39. Domingues MM, Santos NC, Castanho MARB (2012) Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies. Curr Protein Pept Sci 13:611–619
40. Naghmouchi K, Baah J, Hober D et al (2013) Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother 57:2719–2725. doi:10.1128/AAC.02328-12
41. Naghmouchi K, Drider D, Baah J, Teather R (2010) Nisin A and polymyxin B as synergistic inhibitors of Gram-positive and Gram-negative bacteria. Probiot Antimicrob Proteins 2:98–103. doi:10.1007/s12602-009-9033-8
42. Moulton HM (2013) In vivo delivery of morpholino oligos by cell-penetrating peptides. Curr Pharm Des 19:2963–2969
43. Erazo-Oliveras A, Najjar K, Dayani L et al (2014) Protein delivery into live cells by incubation with an endosomolytic agent. Nat Methods 11:861–867. doi:10.1038/nmeth.2998
44. Chen Z, Zhang P, Cheetham AG et al (2014) Controlled release of free doxorubicin from peptide-drug conjugates by drug loading. J Control Release 191:123–130. doi:10.1016/j.jconrel.2014.05.051
45. Hearst SM, Shao Q, Lopez M et al (2014) The design and delivery of a PKA inhibitory polypeptide to treat SCA1. J Neurochem. doi:10.1111/jnc.12782
46. Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193
47. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 88:1864–1868
48. Elmquist A, Lindgren M, Bartfai T, Langel U (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269:237–244. doi:10.1006/excr.2001.5316
49. Tunnemann G, Ter-Avetisyan G, Martin RM et al (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J Pept Sci 14:469–476. doi:10.1002/psc
50. Oehlke J, Scheller A, Wiesner B et al (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta 1414:127–139
51. Walrant A, Matheron L, Cribier S et al (2013) Direct translocation of cell-penetrating peptides in liposomes: a combined mass spectrometry quantification and fluorescence detection study. Anal Biochem 438:1–10. doi:10.1016/j.ab.2013.03.009
52. Eguchi A, Akuta T, Okuyama H et al (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276:26204–26210. doi:10.1074/jbc.M010625200
53. Chugh A, Amundsen E, Eudes F (2009) Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores. Plant Cell Rep 28:801–810. doi:10.1007/s00299-009-0692-4
54. Splith K, Neundorf I (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40:387–397. doi:10.1007/s00249-011-0682-7
55. Nekhotiaeva N, Elmquist A, Rajarao GK et al (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J 18:394–396. doi:10.1096/fj.03-0449fje
56. Palm C, Netzereab S, Hällbrink M (2006) Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27:1710–1716. doi:10.1016/j.peptides.2006.01.006
57. Zhu WL, Shin SY (2009) Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. J Pept Sci 15:345–352. doi:10.1002/psc.1120
58. Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257. doi:10.1006/bbrc.1998.8159
59. Takeshima K, Chikushi A, Lee K-K et al (2003) Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 278:1310–1315. doi:10.1074/jbc.M208762200
60. Pushpanathan M, Gunasekaran P, Rajendhran J (2013) Mechanisms of the antifungal action of marine metagenome-derived peptide, MMGP1, against Candida albicans. PLoS ONE 8:e69316. doi:10.1371/journal.pone.0069316
61. Fusetani N, Kem W (2009) Marine toxins: an overview. Prog Mol Subcell Biol 46:1–44. doi:10.1007/978-3-540-87895-7_1
62. Parker MW, Feil SC (2005) Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol 88:91–142. doi:10.1016/j.pbiomolbio.2004.01.009
63. Oren Z, Shai Y (1996) A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur J Biochem 237:303–310
64. Fedorov S, Dyshlovoy S, Monastyrnaya M et al (2010) The anticancer effects of actinoporin RTX-A from the sea anemone Heteractis crispa (= Radianthus macrodactylus). Toxicon 55:811–817. doi:10.1016/j.toxicon.2009.11.016
65. Tejuca M, Anderluh G, Macek P et al (1999) Antiparasite activity of sea-anemone cytolysins on Giardia duodenalis and specific targeting with anti-Giardia antibodies. Int J Parasitol 29:489–498
66. Anderluh G, Macek P (2002) Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria). Toxicon 40:111–124
67. Anderluh G, Pungercar J, Strukelj B et al (1996) Cloning, sequencing, and expression of equinatoxin II. Biochem Biophys Res Commun 220:437–442. doi:10.1006/bbrc.1996.0391
68. Anderluh G, Barlic A, Podlesek Z et al (1999) Cysteine-scanning mutagenesis of an eukaryotic pore-forming toxin from sea anemone: topology in lipid membranes. Eur J Biochem 263:128–136
69. Lanio ME, Morera V, Alvarez C et al (2001) Purification and characterization of two hemolysins from Stichodactyla helianthus. Toxicon 39:187–194
70. Wang Y, Chua KL, Khoo HE (2000) A new cytolysin from the sea anemone, Heteractis magnifica: isolation, cDNA cloning and functional expression. Biochim Biophys Acta 1478:9–18
71. Terwilliger TC, Eisenberg D (1982) The structure of melittin. II. Interpretation of the structure. J Biol Chem 257:6016–6022
72. Steiner H (1982) Secondary structure of the cecropins: antibacterial peptides from the moth Hyalophora cecropia. FEBS Lett 137:283–287
73. Hinds MG, Zhang W, Anderluh G et al (2002) Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation. J Mol Biol 315:1219–1229. doi:10.1006/jmbi.2001.5321
74. Jackson KE, Spielmann T, Hanssen E et al (2007) Selective permeabilization of the host cell membrane of Plasmodium falciparum-infected red blood cells with streptolysin O and equinatoxin II. Biochem J 403:167–175. doi:10.1042/BJ20061725
75. Zhang M, Fishman Y, Sher D, Zlotkin E (2003) Hydralysin, a novel animal group-selective paralytic and cytolytic protein from a noncnidocystic origin in hydra. Biochemistry 42:8939–8944. doi:10.1021/bi0343929
76. Sher D, Zlotkin E (2009) A hydra with many heads: protein and polypeptide toxins from hydra and their biological roles. Toxicon 54:1148–1161. doi:10.1016/j.toxicon.2009.02.036
77. Sher D, Fishman Y, Zhang M et al (2005) Hydralysins, a new category of beta-pore-forming toxins in cnidaria. J Biol Chem 280:22847–22855. doi:10.1074/jbc.M503242200
78. Lazarovici P, Primor N, Loew LM (1986) Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J Biol Chem 261:16704–16713
79. Shai Y, Bach D, Yanovsky A (1990) Channel formation properties of synthetic pardaxin and analogues. J Biol Chem 265:20202–20209
80. Hallock KJ, Lee D-K, Omnaas J et al (2002) Membrane composition determines pardaxin’s mechanism of lipid bilayer disruption. Biophys J 83:1004–1013. doi:10.1016/S0006-3495(02)75226-0
81. Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta 1758:1499–1512. doi:10.1016/j.bbamem.2006.07.007
82. Blumenthal KM (1982) Structure and action of heteronemertine polypeptide toxins. Membrane penetration by Cerebratulus lacteus toxin A-III. Biochemistry 21:4229–4233
83. Kem WR (1994) Structure and membrane actions of a marine worm protein cytolysin, Cerebratulus toxin A-III. Toxicology 87:189–203
84. Lehrer RI, Lee IH, Menzel L et al (2001) Clavanins and styelins, alpha-helical antimicrobial peptides from the hemocytes of Styela clava. Adv Exp Med Biol 484:71–76
85. Pundir P, Catalli A, Leggiadro C et al (2014) Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol 7:177–187. doi:10.1038/mi.2013.37
86. Lee S-A, Kim YK, Lim SS et al (2007) Solution structure and cell selectivity of piscidin 1 and its analogues. Biochemistry 46:3653–3663. doi:10.1021/bi062233u
87. Pushpanathan M, Rajendhran J, Jayashree S et al (2012) Identification of a novel antifungal peptide with chitin-binding property from marine metagenome. Protein Pept Lett 19:1289–1296
88. Kolusheva S, Lecht S, Derazon Y et al (2008) Pardaxin, a fish toxin peptide interaction with a biomimetic phospholipid/polydiacetylene membrane assay. Peptides 29:1620–1625. doi:10.1016/j.peptides.2008.05.012
89. Bringezu F, Wen S, Dante S et al (2007) The insertion of the antimicrobial peptide dicynthaurin monomer in model membranes: thermodynamics and structural characterization. Biochemistry 46:5678–5686. doi:10.1021/bi7001295
90. Jang WS, Kim KN, Lee YS et al (2002) Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett 521:81–86
91. Cespedes GF, Lorenzón EN, Vicente EF et al (2012) Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus. Protein Pept Lett 19:596–603
92. Stensvåg K, Haug T, Sperstad SV et al (2008) Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Dev Comp Immunol 32:275–285. doi:10.1016/j.dci.2007.06.002
93. Sperstad SV, Haug T, Vasskog T, Stensvåg K (2009) Hyastatin, a glycine-rich multi-domain antimicrobial peptide isolated from the spider crab (Hyas araneus) hemocytes. Mol Immunol 46:2604–2612. doi:10.1016/j.molimm.2009.05.002
94. Yang Y, Poncet J, Garnier J et al (2003) Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide. J Biol Chem 278:36859–36867. doi:10.1074/jbc.M305450200
95. Roch P, Yang Y, Toubiana M, Aumelas A (2008) NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides. Dev Comp Immunol 32:227–238. doi:10.1016/j.dci.2007.05.006
96. Bakrac B, Gutiérrez-Aguirre I, Podlesek Z et al (2008) Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin. J Biol Chem 283:18665–18677. doi:10.1074/jbc.M708747200
97. Mancheño JM, Martín-Benito J, Martínez-Ripoll M et al (2003) Crystal and electron microscopy structures of sticholysin II actinoporin reveal insights into the mechanism of membrane pore formation. Structure 11:1319–1328. doi:10.1016/j.str.2003.09.019
98. Athanasiadis A, Anderluh G, Maček P, Turk D (2001) Crystal structure of the soluble form of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina. Structure 9:341–346. doi:10.1016/S0969-2126(01)00592-5
99. Hong Q, Gutierrez-Aguirre I, Barlic A et al (2002) Two-step membrane binding by equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. Biochemistry 277:41916–41924. doi:10.1074/jbc.M204625200
100. Alegre-Cebollada J, Cunietti M, Herrero-Galán E et al (2008) Calorimetric scrutiny of lipid binding by sticholysin II toxin mutants. J Mol Biol 382:920–930. doi:10.1016/j.jmb.2008.07.053
101. Malovrh P, Viero G, Serra MD et al (2003) A novel mechanism of pore formation: membrane penetration by the N-terminal amphipathic region of equinatoxin. J Biol Chem 278:22678–22685. doi:10.1074/jbc.M300622200
102. Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236–248. doi:10.1002/bip.10260
103. La Rocca P, Biggin PC, Tieleman DP, Sansom MS (1999) Simulation studies of the interaction of antimicrobial peptides and lipid bilayers. Biochim Biophys Acta 1462:185–200
104. Gazit E, Lee WJ, Brey PT, Shai Y (1994) Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry 33:10681–10692
105. Stark M, Liu L-P, Deber CM (2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother 46:3585–3590
106. Shai Y, Oren Z (2001) From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629–1641
107. Gidalevitz D, Ishitsuka Y, Muresan AS et al (2003) Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci USA 100:6302–6307. doi:10.1073/pnas.0934731100
108. Yang L, Harroun TA, Weiss TM et al (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81:1475–1485. doi:10.1016/S0006-3495(01)75802-X
109. Spaar A, Münster C, Salditt T (2004) Conformation of peptides in lipid membranes studied by X-ray grazing incidence scattering. Biophys J 87:396–407. doi:10.1529/biophysj.104.040667
110. Murzyn K, Pasenkiewicz-Gierula M (2003) Construction of a toroidal model for the magainin pore. J Mol Model 9:217–224. doi:10.1007/s00894-003-0127-z
111. Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758:1292–1302. doi:10.1016/j.bbamem.2006.02.001
112. Anderluh G, Dalla Serra M, Viero G et al (2003) Pore formation by equinatoxin II, a eukaryotic protein toxin, occurs by induction of nonlamellar lipid structures. J Biol Chem 278:45216–45223. doi:10.1074/jbc.M305916200
113. Alvarez C, Mancheño JM, Martínez D et al (2009) Sticholysins, two pore-forming toxins produced by the Caribbean Sea anemone Stichodactyla helianthus: their interaction with membranes. Toxicon 54:1135–1147. doi:10.1016/j.toxicon.2009.02.022
114. Park CB, Lee JH, Park IY et al (1997) A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus. FEBS Lett 411:173–178
115. Jung HJ, Park Y, Sung WS et al (2007) Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. Biochim Biophys Acta 1768:1400–1405. doi:10.1016/j.bbamem.2007.02.024
116. Lauth X, Shike H, Burns JC et al (2002) Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem 277:5030–5039. doi:10.1074/jbc.M109173200
117. Broekman DC, Zenz A, Gudmundsdottir BK et al (2011) Functional characterization of codCath, the mature cathelicidin antimicrobial peptide from Atlantic cod (Gadus morhua). Peptides 32:2044–2051. doi:10.1016/j.peptides.2011.09.012
118. Pan C-Y, Chen J-Y, Cheng Y-SE et al (2007) Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection. DNA Cell Biol 26:403–413. doi:10.1089/dna.2006.0564
119. Shiomi K, Igarashi T, Yokota H et al (2000) Isolation and structures of grammistins, peptide toxins from the skin secretion of the soapfish Grammistes sexlineatus. Toxicon 38:91–103
120. Campagna S, Saint N, Molle G, Aumelas A (2007) Structure and mechanism of action of the antimicrobial peptide piscidin. Biochemistry 46:1771–1778. doi:10.1021/bi0620297
121. Sato K, Horibe K, Amano K et al (2006) Membrane permeabilization induced by discodermin A, a novel marine bioactive peptide. Toxicon 39:259–264
122. Matsunaga S, Fusetani N, Hashimoto K, Walchli M (1989) Theonellamide F. A novel antifungal bicyclic peptide from a marine sponge Theonella sp. J Am Chem Soc 111:2582–2588. doi:10.1021/ja00189a035
123. Li HY, Matsunaga S, Fusetani N (1995) Halicylindramides A-C, antifungal and cytotoxic depsipeptides from the marine sponge Halichondria cylindrata. J Med Chem 38:338–343
124. Ovchinnikova TV, Balandin SV, Aleshina GM et al (2006) Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins. Biochem Biophys Res Commun 348:514–523. doi:10.1016/j.bbrc.2006.07.078
125. Pan W, Liu X, Ge F et al (2004) Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. J Biochem 135:297–304
126. Tasiemski A, Schikorski D, Le Marrec-Croq F et al (2007) Hedistin: a novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor. Dev Comp Immunol 31:749–762. doi:10.1016/j.dci.2006.11.003
127. Lee J-U, Kang D-I, Zhu WL et al (2007) Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative. Biopolymers 88:208–216. doi:10.1002/bip.20700
128. Tasiemski A, Vandenbulcke F, Mitta G et al (2004) Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum. J Biol Chem 279:30973–30982. doi:10.1074/jbc.M312156200
129. Destoumieux D, Munoz M, Bulet P, Bachère E (2000) Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda). Cell Mol Life Sci 57:1260–1271
130. Noga EJ, Stone KL, Wood A et al (2011) Primary structure and cellular localization of callinectin, an antimicrobial peptide from the blue crab. Dev Comp Immunol 35:409–415. doi:10.1016/j.dci.2010.11.015
131. Lee SY, Lee BL, Söderhäll K (2003) Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus. J Biol Chem 278:7927–7933. doi:10.1074/jbc.M209239200
132. Nakamura T, Furunaka H, Miyata T et al (1988) Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem 263:16709–16713
133. Osaki T, Omotezako M, Nagayama R et al (1999) Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins. J Biol Chem 274:26172–26178
134. Charlet M, Chernysh S, Philippe H et al (1996) Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J Biol Chem 271:21808–21813
135. Mitta G, Hubert F, Noël T, Roch P (1999) Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis. Eur J Biochem 265:71–78
136. Mitta G, Vandenbulcke F, Hubert F, Roch P (1999) Mussel defensins are synthesised and processed in granulocytes then released into the plasma after bacterial challenge. J Cell Sci 112(Pt 2):4233–4242
137. Andrä J, Jakovkin I, Grötzinger J et al (2008) Structure and mode of action of the antimicrobial peptide arenicin. Biochem J 410:113–122. doi:10.1042/BJ20071051
138. Dennison SR, Phoenix AJ, Phoenix DA (2012) Effect of salt on the interaction of Hal18 with lipid membranes. Eur Biophys J 41:769–776. doi:10.1007/s00249-012-0840-6
139. Shin YP, Park HJ, Shin SH et al (2010) Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrob Agents Chemother 54:2855–2866. doi:10.1128/AAC.01790-09
140. Lin W, Liu S, Hu L, Zhang S (2014) Characterization and bioactivity of hepcidin-2 in zebrafish: dependence of antibacterial activity upon disulfide bridges. Peptides 57:36–42. doi:10.1016/j.peptides.2014.04.014
141. Andreu D, Rivas L (1998) Animal antimicrobial peptides: an overview. Biopolymers 47:415–433. doi:10.1002/(SICI)1097-0282(1998)47:6<415:AID-BIP2>3.0.CO;2-D
142. Lee IH, Cho Y, Lehrer RI (1997) Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 65:2898–2903
143. Van Kan EJM, Demel RA, Breukink E et al (2002) Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 41:7529–7539
144. Lehrer RI, Andrew Tincu J, Taylor SW et al (2003) Natural Peptide antibiotics from tunicates: structures, functions and potential uses. Integr Comp Biol 43:313–322. doi:10.1093/icb/43.2.313
145. Gulavita NK, Gunasekera SP, Pomponi SA, Robinson EV (1992) Polydiscamide A: a new bioactive depsipeptide from the marine sponge Discodermia sp. J Org Chem 57:1767–1772. doi:10.1021/jo00032a031
146. Azumi K, Yokosawa H, Ishii S (1990) Halocyamines: novel antimicrobial tetrapeptide-like substances isolated from the hemocytes of the solitary ascidian Halocynthia roretzi. Biochemistry 29:159–165
147. Tincu JA, Menzel LP, Azimov R et al (2003) Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes. J Biol Chem 278:13546–13553. doi:10.1074/jbc.M211332200
148. Kato Y, Fusetani N, Matsunaga S et al (1988) Bioactive marine metabolites. 24. Isolation and structure elucidation of calyculins B, C, and D, novel antitumor metabolites, from the marine sponge Discodermia calyx. J Org Chem 53:3930–3932. doi:10.1021/jo00252a009
149. Capon RJ, Ford J, Lacey E et al (2002) Phoriospongin A and B: two new nematocidal depsipeptides from the Australian marine sponges Phoriospongia sp. and Callyspongia bilamellata. J Nat Prod 65:358–363
150. Monastyrnaya MM, Zykova TA, Apalikova OV et al (2002) Biologically active polypeptides from the tropical sea anemone Radianthus macrodactylus. Toxicon 40:1197–1217
151. Grotendorst GR, Hessinger DA (1999) Purification and partial characterization of the phospholipase A2 and co-lytic factor from sea anemone (Aiptasia pallida) nematocyst venom. Toxicon 37:1779–1796
152. Cline EI, Wiebe LI, Young JD, Samuel J (1995) Toxic effects of the novel protein UpI from the sea anemone Urticina piscivora. Pharmacol Res 32:309–314
153. Bernheimer AW, Lois SA (1978) A cholesterol-inhibitable cytolytic from the sea anemone Metridium senile. Biochim Biophys Acta 541:96–106. doi:10.1016/0304-4165(78)90270-2